Ignore nalanijjcmahood, the spambot. History of just three posts, all within six minutes and the second of which was spam for Underground Stock Alerts. Sandwich replies, copied from other threads, appear to be a new spambot tactic to elude Yahoo! message board anti-spam algorithms; the replies may not be contextual. The first, in this case, was copied from ed.jmfb2win's Sep 17 reply to mister_luckee's "Highest close since Feb 12, 2012" thread. The second was copied from fredd369's Sep 18 reply to wprule in fredd369's "warned u guys this was a scam" thread. (Sorry, have an eidetic memory for inconsequential trivia). Activity was repeated in a broad-based assault on multiple message boards Oct 4 - 6.
I would have to turn the monitor upside down to see weakening in the chart at which I'm looking to the right of your message.
Scramble to cover by shorts? OTCBB short interest for CTSO as of August 15 was only 3,280 shares. Don't take my word for it, go to the OTCBB and see for yourself.
Most companies announce quarterly conference calls thirty days or more in advance. Likely just Kathleen Bloch whipping the boys into shape and telling them, "This is how you run a public company."
Ping Pow Princess periodically has summarized upcoming events for us. Let me try that again. Ping Pow Princess periodically provides presentation plans, prompting post-presentation pumper price predictions.
Stop and think what is happening. Share prices of other companies that retreated ~ 5% due to the budget stalemate in Washington are rallying on prospects of a budget resolution. Why would CTSO be among them if the share price was unaffected by unseemly Washington politics and has hovered around ten cents (rounded) longer than any of us care to recall? You must buy a larger capitalization stock on the dips if you want to play the broader market game. One holds CTSO for a different reason.
Patients succumbing to sepsis tend to do so very quickly. Why do you focus on morbidity rates after 60 days?
Maybe it's a relief rally that one of the big hedge funds tormenting SPPI over the years has been brought to justice.
It's the middle of the night in India. You just wait until they awaken and read about Cytosorbents. LOL
Speaking of MAKO, apparently Zacks uses bots rather than analysts to evaluate stocks. Zacks put out a piece today that says MAKO has reached oversold territory and investors should sell "before it falls back to earth". No mention of the Stryker acquisition. LOL, makes one wonder if a Zacks bot continues to reiterate a $0.50 price target for CTSO, oblivious to the impact of LPC funding.
Acknowledgment of prospective viability of the technology by NIH is a significant milestone, but a larger immediate cash infusion from licensing HemoDefend would have been better.
CNBC script writers in India appear as knowledgeable as their American counterparts. A sepsis drug? Fortunately, for those not caring to watch the videoclip, Biocon's CEO corrected the CNBC anchors' misstatement.
Why doesn't CTSO stop selling common stock and use the other sources of capital? Issuing common stock is the lowest cost source of capital, because shareholders pay for it.
Seems to be similar to politics and religion; where once certain people make up their minds, they refuse to consider other perspectives.
Many bought here heavy at 45? You can't be serious. Fewer than 2M shares traded from March 26 - 27, 2012, the only two days MAKO traded at 45.
What kind of person creates such an alias? I am sorry you choose to harbor such generalized animosity toward other people.
Don't attribute too much significance to the fact. Mentioning CTSO and the other stocks is a trick to get clicks on their MDT report to generate Yahoo! advertising revenue to offset the cost of their own advertisement on the webpage.